Drug General Information (ID: DDIW6H5LTZ)
  Drug Name Alprostadil Drug Info Heparin Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Vasodilator Agents Anticoagulants
  Structure

 Mechanism of Alprostadil-Heparin Interaction (Severity Level: Moderate)
     Increased risk of bleeding Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Alprostadil Heparin
      Mechanism Risk of bleeding
Antiplatelet effects 
Risk of bleeding
Anticoagulant 
      Key Mechanism Factor 1
Factor Name Bleeding
Factor Description Patients may be at risk for bleeding when the outcome of a disease or disease treatment confounds the standard mechanisms for maintaining hemostasis. Signs or symptoms of abnormal bleeding include: bleeding that takes a long time to stop (including nosebleeds, bleeding gums, bleeding from cuts and abrasions, and menstrual bleeding); severe unexplained bruising, or bruising that becomes larger; blood in the urine or stool, etc.
      Mechanism Description
  • Increased risk of bleeding by the combination of Alprostadil and Heparin 

Recommended Action
      Management The manufacturers recommend caution when alprostadil is administered to neonates with bleeding tendencies.

References
1 Agencia Espaola de Medicamentos y Productos Sanitarios Healthcare "Centro de informacion online de medicamentos de la AEMPS - CIMA.".
2 Cerner Multum, Inc. "Australian Product Information.".
3 Cerner Multum, Inc. "UK Summary of Product Characteristics.".
4 Product Information. Prostin VR Pediatric Sterile Solution (alprostadil) Pharmacia and Upjohn, Kalamazoo, MI.